Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of sports injuries and orthopedic conditions
3.2.1.2 Growing cosmetic and aesthetic applications
3.2.1.3 Increasing awareness and acceptance of regenerative medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost
3.2.2.2 Lack of standardization
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Pure platelet-rich plasma (P-PRP)
5.3 Leukocyte- and platelet rich plasma (L-PRP)
5.4 Other types
Chapter 6 Market Estimates and Forecast, By Origin, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Autologous
6.3 Allogenic
6.4 Homologous
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Orthopedics & sports medicine
7.3 Cosmetic surgery and dermatology
7.4 Neurology
7.5 Cardiology
7.6 Ophthalmology
7.7 Other applications
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Specialty clinics
8.4 Ambulatory surgical centers
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Netherlands
9.3.8 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Arthrex Inc.
10.2 APEX Biologix
10.3 Celling Biosciences, Inc.
10.4 DePuy Synthes (Johnson & Johnson)
10.5 Dr. PRP USA LLC
10.6 EmCyte Corporation
10.7 Exactech, Inc.
10.8 Glofinn Oy
10.9 Isto Biologics
10.10 Juventix Regenerative Medical, LLC.
10.11 Regen Lab SA
10.12 Terumo BCT, Inc.
10.13 ThermoGenesis Holdings Inc.
10.14 Vivostat A/S
